Abstract
We determined the in vitro susceptibilities of 54 isolates of Haemophilus ducreyi from Thailand (29 isolates) and San Francisco (25 isolates) to penicillin G, tetracycline, amoxicillin-clavulanic acid, ceftriaxone, cefixime, erythromycin, azithromycin, ciprofloxacin, ofloxacin, and trimethoprim-sulfamethoxazole. Isolates were susceptible to < or = 0.25 microgram of ceftriaxone per ml, < or less 0.5 microgram of cefixime per ml, < or = 0.125 microgram of ciprofloxacin per ml, and < or = 0.06 microgram of ofloxacin per ml. Erythromycin was active against all isolates (MIC for 90% of isolates tested, 0.25 microgram/ml), as was azithromycin (MIC, < or = micrograms/ml). In contrast, all but one isolate were resistant to > or = 8.0 micrograms of tetracycline per ml, 11.1% of the isolates were resistant to and 40.9% of the isolates were resistant to trimethoprim-sulfamethoxazole (MIC, > or = 4/76 microgram/ml.)
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abeck D., Johnson A. P., Dangor Y., Ballard R. C. Antibiotic susceptibilities and plasmid profiles of Haemophilus ducreyi isolates from southern Africa. J Antimicrob Chemother. 1988 Oct;22(4):437–444. doi: 10.1093/jac/22.4.437. [DOI] [PubMed] [Google Scholar]
- Albritton W. L., Brunton J. L., Slaney L., MacLean I. Plasmid-mediated sulfonamide resistance in Haemophilus ducreyi. Antimicrob Agents Chemother. 1982 Jan;21(1):159–165. doi: 10.1128/aac.21.1.159. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dangor Y., Miller S. D., Exposto F. da L., Koornhof H. J. Antimicrobial susceptibilities of southern African isolates of Haemophilus ducreyi. Antimicrob Agents Chemother. 1988 Sep;32(9):1458–1460. doi: 10.1128/aac.32.9.1458. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dylewski J., Nsanze H., D'Costa L., Slaney L., Ronald A. Trimethoprim sulphamoxole in the treatment of chancroid. Comparison of two single dose treatment regimens with a five day regimen. J Antimicrob Chemother. 1985 Jul;16(1):103–109. doi: 10.1093/jac/16.1.103. [DOI] [PubMed] [Google Scholar]
- Girouard Y. C., Maclean I. W., Ronald A. R., Albritton W. L. Synergistic antibacterial activity of clavulanic acid and amoxicillin against beta-lactamase-producing strains of Haemophilus ducreyi. Antimicrob Agents Chemother. 1981 Jul;20(1):144–145. doi: 10.1128/aac.20.1.144. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jones B. M., Kinghorn G. R., Duerden B. I. In vitro activity of azithromycin and erythromycin against organisms associated with bacterial vaginosis and chancroid. Eur J Clin Microbiol Infect Dis. 1988 Aug;7(4):551–553. doi: 10.1007/BF01962614. [DOI] [PubMed] [Google Scholar]
- Morse S. A. Chancroid and Haemophilus ducreyi. Clin Microbiol Rev. 1989 Apr;2(2):137–157. doi: 10.1128/cmr.2.2.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Motley M., Sarafian S. K., Knapp J. S., Zaidi A. A., Schmid G. Correlation between in vitro antimicrobial susceptibilities and beta-lactamase plasmid contents of isolates of Haemophilus ducreyi from the United States. Antimicrob Agents Chemother. 1992 Aug;36(8):1639–1643. doi: 10.1128/aac.36.8.1639. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sanson-Le Pors M. J., Casin I., Ortenberg M., Perol Y. In-vitro susceptibility of thirty strains of Haemophilus ducreyi to several antibiotics including six cephalosporins. J Antimicrob Chemother. 1983 Mar;11(3):271–280. doi: 10.1093/jac/11.3.271. [DOI] [PubMed] [Google Scholar]
- Sarafian S. K., Johnson S. R., Thomas M. L., Knapp J. S. Novel plasmid combinations in Haemophilus ducreyi isolates from Thailand. J Clin Microbiol. 1991 Oct;29(10):2333–2334. doi: 10.1128/jcm.29.10.2333-2334.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sarafian S. K., Knapp J. S. Molecular epidemiology, based on plasmid profiles, of Haemophilus ducreyi infections in the United States. Results of surveillance, 1981-1990. Sex Transm Dis. 1992 Jan-Feb;19(1):35–38. doi: 10.1097/00007435-199201000-00007. [DOI] [PubMed] [Google Scholar]
- Schmid G. P. The treatment of chancroid. JAMA. 1986 Apr 4;255(13):1757–1762. [PubMed] [Google Scholar]
- Taylor D. N., Pitarangsi C., Echeverria P., Panikabutra K., Suvongse C. Comparative study of ceftriaxone and trimethoprim-sulfamethoxazole for the treatment of chancroid in Thailand. J Infect Dis. 1985 Nov;152(5):1002–1006. doi: 10.1093/infdis/152.5.1002. [DOI] [PubMed] [Google Scholar]